Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06989333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Local Spraying of GM-CSF Via Bronchoscopy in the Treatment of Autoimmune Pulmonary Alveolar Proteinosis

Study acronym: aPAP and GMCSF
StatusNot Yet Recruiting
PhasePhase 2
SponsorJiuwu Bai
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to explore a new therapeutic approach: the feasibility, safety and preliminary efficacy of directly spraying GM-CSF into the airway through bronchoscopy for the treatment of aPAP.
Trial Details
NCT Number NCT06989333
Lead Sponsor Jiuwu Bai
Conditions
(from sponsor)		 Pulmonary Alveolar Proteinosis
Related terms Pulmonary Alveolar Proteinosis
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov